{"contentid": 487908, "importid": NaN, "name": "Time to reform pricing and reimbursement and procurement, says Medicines for Europe", "introduction": "A new report from Medicines for Europe has been highlighted by the group as evidence of the need for pricing and reimbursement and procurement reforms to ensure patient access and healthcare sustainability.", "content": "<p>A new report from Medicines for Europe has been highlighted by the group as evidence of the need for pricing and reimbursement and procurement reforms to ensure patient access and healthcare sustainability.</p>\n<p>The 2020 Generic Market Review provides a comprehensive overview of generic medicine policies in 22 European countries. It covers pricing systems, control of excessive spending, retail tendering, hospital tendering, reimbursement systems, physician incentives, pharmacist incentives and patient incentives.</p>\n<p><span class=\"pullQuote\">\"The report clearly shows the need for pricing and reimbursement and procurement reforms\"</span>Medicines for Europe represents the continent&rsquo;s generic and biosimilar medicines manufacturers.</p>\n<p>Its director general Adrian van den Hoven said: &ldquo;The report clearly shows the need for pricing and reimbursement and procurement reforms in order to expand patient access, promote sustainable uptake of generic medicines and increase security of supply. Unsustainable medicines policies, like unpredictable clawback policies and price cuts, have to be avoided at all cost.&rdquo;</p>\n<p>Tender reforms, pricing and reimbursement reforms and greater use of generic medicines are essential to ensure patients can access the medicines they need and to enhance healthcare sustainability, according to Medicines for Europe. To fully realize generics&rsquo; potential, effective and comprehensive generic medicines policies are required, the group argues.</p>\n<p>The Medicines for Europe report is available <a href=\"https://www.medicinesforeurope.com/wp-content/uploads/2021/02/2020-Generic-Market-Review-Final.pdf\" target=\"_blank\" rel=\"follow noopener\">here</a>.</p>", "date": "2021-03-01 16:30:00", "meta_title": NaN, "meta_keywords": "medicines, pricing, reimbursement, procurement, Europe, reforms, report, generic, patient, access, group, healthcare, sustainability, ensure, policies, Tim", "meta_description": "A new report from Medicines for Europe has been highlighted by the group as evidence of the need for pricing and reimbursement and procurement reforms to ensure", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-03-01 16:26:40", "updated": "2021-03-01 17:12:23", "access": NaN, "url": "https://www.thepharmaletter.com/article/time-to-reform-pricing-and-reimbursement-and-procurement-says-medicines-for-europe", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "generic_big.jpg", "image2id": "generic_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Generics", "therapy area_tag": NaN, "topic_tag": "Government Affairs, Health Medical Pharma", "geography_tag": "Europe", "company_tag": NaN, "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-03-01 16:30:00"}